Ahead of the threatened tariffs, front-running of orders looks to have been particularly steep in the pharmaceutical sector. Factory output recorded a strong rebound in May in Ireland, where pharma ...

From Microsoft and Google to Chanel and DBS, Indian-origin leaders born in small towns and cities now sit at the helm of ...

Karnataka CM Siddaramaiah had on Tuesday said "hasty approval and distribution" of the Covid vaccine to the public could also be a reason for the deaths of more than 20 people due to heart attacks in ...

Australia’s Snowy 2.0 project’s newest Herrenknecht TBM – measuring 178m long, with eight trailing gantries, and a cutterhead ...

Global manufacturers are constantly revamping their network of plants. Surviving over the long term for a factory—especially ...

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his team went through individual scans and interviewed investigators ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.

Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until after the 2020 election ...

Pfizer's Oncology Transformation: Why This Beaten-Down Pharma Giant Is Poised For A Strong Comeback Despite trading near decade-low valuations, Pfizer ...

Pfizer exits Sanford, North Carolina jobs deal after Abzena acquisition. Drugmaker cites economic climate for not meeting Lee County hiring and investment goals.